Duan Ma Selected Research

Tetralogy of Fallot (Fallot Tetralogy)

1/2022	WDR62 variants contribute to congenital heart disease by inhibiting cardiomyocyte proliferation.
1/2020	Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.
1/2017	Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation.
5/2014	Expression of Cx43-related microRNAs in patients with tetralogy of Fallot.
5/2014	Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF.
4/2014	[Sequence analyses of HIRA gene 3'UTR region and related microRNA].
12/2013	MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot.
10/2013	[Histone acetylation and expression of acetylation-related enzymes in children with tetralogy of Fallot].
9/2013	Association between mRNA levels of DNMT1, DNMT3A, DNMT3B, MBD2 and LINE-1 methylation status in infants with tetralogy of Fallot.
5/2012	DNA sequencing of TGFβ2 in sporadic patients with tetralogy of Fallot.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Duan Ma Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 02/2004
10	Tetralogy of Fallot (Fallot Tetralogy) 01/2022 - 05/2012
10	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2004
6	Carcinogenesis 01/2021 - 03/2013
6	Hearing Loss (Hearing Impairment) 10/2019 - 01/2013
5	Congenital Heart Defects (Congenital Heart Defect) 02/2021 - 07/2010
5	Ovarian Neoplasms (Ovarian Cancer) 02/2015 - 10/2009
4	Inflammation (Inflammations) 04/2022 - 06/2005
4	Gaucher Disease (Gaucher's Disease) 01/2022 - 01/2015
4	Pre-Eclampsia (Preeclampsia) 06/2020 - 06/2010
4	Malignant Fibrous Histiocytoma 03/2018 - 01/2015
4	Atherosclerosis 02/2017 - 01/2009
4	Breast Neoplasms (Breast Cancer) 03/2013 - 12/2007
3	Congenital Microtia 05/2022 - 04/2013
3	Obesity 04/2022 - 09/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
3	Neuroblastoma 10/2020 - 11/2016
3	Proteinuria 06/2020 - 06/2015
3	Deafness (Deaf Mutism) 01/2015 - 12/2011
3	Down Syndrome (Down's Syndrome) 07/2014 - 02/2011
3	Glomerulonephritis 03/2010 - 11/2008
2	Body Weight (Weight, Body) 04/2022 - 01/2013
2	Chronic Renal Insufficiency 01/2022 - 11/2019
2	Osteoporosis 01/2022 - 11/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2016
2	Glioma (Gliomas) 01/2021 - 01/2020
2	Hepatoblastoma 01/2021 - 12/2020
2	Hypertension (High Blood Pressure) 06/2020 - 02/2017
2	Thrombosis (Thrombus) 09/2017 - 01/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 08/2014
2	Atherosclerotic Plaque (Atheroma) 09/2013 - 08/2011
2	Fibrosarcoma 01/2012 - 02/2004
2	Insulin Resistance 03/2011 - 10/2009
2	Ovarian Epithelial Carcinoma 09/2010 - 10/2009
1	Periodontal Diseases (Periodontal Disease) 04/2022
1	Periodontitis 04/2022
1	Alveolar Bone Loss 04/2022
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Endotoxemia 04/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Cleft Lip (Harelip) 01/2021
1	Cancer Pain 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2007
13	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2008
8	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2017 - 06/2005
8	tissue-factor-pathway inhibitor 2 (PP5)IBA 10/2015 - 02/2004
7	Long Noncoding RNAIBA 02/2021 - 03/2017
6	Messenger RNA (mRNA)IBA 05/2022 - 12/2007
6	Thromboplastin (Tissue Factor)IBA 02/2017 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 12/2007
5	Mitochondrial DNA (mtDNA)IBA 01/2022 - 03/2011
5	Biological ProductsIBA 12/2020 - 06/2005
4	RNA (Ribonucleic Acid)IBA 05/2022 - 10/2016
4	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2012
4	3' Untranslated Regions (3' UTR)IBA 01/2017 - 03/2011
3	CateninsIBA 01/2022 - 02/2014
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022 - 05/2016
3	Histones (Histone)IBA 11/2021 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2009
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 03/2018 - 10/2009
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2015
3	EnzymesIBA 10/2013 - 01/2011
3	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 02/2004
2	AdiponectinIBA 04/2022 - 10/2009
2	Pharmaceutical PreparationsIBA 04/2022 - 01/2021
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 06/2018
2	LuciferasesIBA 01/2022 - 12/2007
2	ChromatinIBA 11/2021 - 12/2007
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2013
2	Phosphates (Orthophosphate)IBA 08/2019 - 10/2009
2	CytokinesIBA 03/2018 - 01/2017
2	Hemostatics (Antihemorrhagics)IBA 09/2017 - 01/2011
2	Apolipoproteins E (ApoE)IBA 02/2017 - 09/2013
2	Glucosylceramides (Glucocerebrosides)IBA 05/2016 - 01/2015
2	AcidsIBA 05/2016 - 05/2014
2	Ethanol (Ethyl Alcohol)IBA 11/2015 - 06/2014
2	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 03/2013 - 01/2012
2	LipidsIBA 12/2010 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 01/2008
2	TrypsinIBA 12/2007 - 02/2004
2	Fibrinolysin FDA Link 12/2007 - 02/2004
2	Enzyme Precursors (Zymogens)IBA 12/2007 - 02/2004
1	Apolipoprotein C-II (ApoC2)IBA 05/2022
1	Hormones (Hormone)IBA 04/2022
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	AdipoRonIBA 04/2022
1	Adiponectin ReceptorsIBA 04/2022
1	CreatinineIBA 01/2022
1	TensinsIBA 01/2022
1	Annexin A2 (Annexin II)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2015
2	Lasers (Laser) 01/2012 - 10/2009
1	Fluid Therapy (Oral Rehydration Therapy) 01/2021